Valuation: Fresenius SE & Co. KGaA

Market Cap 23.56B 26.95B 21.79B 19.99B 37.84B 2,597B 38.5B 260B 102B 1,268B 101B 99B 4,379B P/E 2026 *
12.5x
P/E 2027 * 11.3x
Enterprise Value 33.91B 38.79B 31.36B 28.78B 54.46B 3,738B 55.41B 374B 147B 1,825B 146B 142B 6,302B EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.34x
Free-Float
72.98%
Yield 2026 *
2.72%
Yield 2027 * 2.95%
1 day-0.53%
1 week-0.92%
Current month+4.65%
1 month+7.89%
3 months-5.34%
6 months-16.05%
Current year-14.60%
1 week 40.4
Extreme 40.4
42.49
1 month 38.76
Extreme 38.76
44.07
Current year 35.11
Extreme 35.11
52.96
1 year 35.11
Extreme 35.11
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
28/05/26 Buy

Chief Executive Officer

276 0.0000%
28/05/26 Buy

Chief Executive Officer

1,571 0.0003%
28/05/26 Buy

Chief Executive Officer

1,603 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.92%+2.17%+60.21% 26.95B
+0.56%+3.59%+66.93%+49.20% 136B
+1.82%-5.69%+6.39%+30.07% 85.57B
+3.79%+0.65%+25.37%+49.11% 23.18B
+1.27%+0.75%-16.17%-28.01% 20.05B
+3.57%-3.66%+14.89%+143.22% 17.16B
-0.39%+2.05%+6.72%+12.23% 15.47B
+1.04%+1.97%+66.89%+125.57% 15.02B
-0.17%+0.50%-9.38%-10.11% 12.78B
-1.12%-1.82%-12.47%+77.84% 11.1B
Average +0.96%-0.11%+15.13%+50.93% 36.32B
Weighted average by Cap. +1.06%+0.02%+30.48%+46.06%

Financials

2026 *2027 *
Net sales 23.62B 27.02B 21.84B 20.05B 37.94B 2,604B 38.6B 261B 102B 1,272B 101B 99.25B 4,390B 24.83B 28.41B 22.97B 21.08B 39.89B 2,738B 40.58B 274B 108B 1,337B 107B 104B 4,616B
Net income 1.89B 2.17B 1.75B 1.61B 3.04B 209B 3.1B 20.9B 8.21B 102B 8.14B 7.96B 352B 2.12B 2.43B 1.96B 1.8B 3.41B 234B 3.47B 23.41B 9.2B 114B 9.12B 8.92B 394B
Net Debt 10.35B 11.84B 9.57B 8.78B 16.62B 1,141B 16.91B 114B 44.84B 557B 44.46B 43.49B 1,923B 9.6B 10.98B 8.88B 8.15B 15.42B 1,058B 15.69B 106B 41.59B 517B 41.24B 40.33B 1,784B
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.; - other (3.1%).
Employees
177,783
Date Price Change Volume
16/07/26 €41.83 +0.14% 784,302
15/07/26 €41.77 +1.83% 694,868
14/07/26 €41.02 -1.61% 775,204
13/07/26 €41.69 -2.07% 819,141
10/07/26 €42.57 +0.83% 1,049,701
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
41.83EUR
Average target price
54.22EUR
Spread / Average Target
+29.62%

Quarterly revenue - Rate of surprise